MEDTR vs ECILC Comparison
Price, market cap, valuation, profitability and leverage metrics of MEDTR and ECILC side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | MEDTR | ECILC | Sector median |
|---|---|---|---|
| Last price (TL) | 18.14 | 64.05 | 18.72 |
| Daily change | −6.49% | −6.50% | −6.49% |
| Market cap | TRY 2.2B | TRY 43.9B | TRY 4.3B |
| P/E | 66.43 | — | 17.31 |
| P/B | 0.69 | 0.68 | 1.08 |
| Dividend yield | 0.44% | 2.04% | 0.90% |
| Return on equity | 1.14% | −3.08% | 1.78% |
| Free float | 20.21% | 22.02% | 37.21% |
Popular Comparisons
Related Pages
About the MEDTR vs ECILC Comparison
Price, market cap, valuation multiples, profitability and leverage of MEDTR (Meditera Tibbi Malzeme) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 28, 2026, 15:00. Of the 14 metrics compared, MEDTR leads in 9 and ECILC leads in 5.
Highlights: Daily change: MEDTR leads (−6.49% vs −6.50%). Market cap: ECILC leads (TRY 43.9B vs TRY 2.2B). P/B: ECILC leads (0.68 vs 0.69). EV/EBITDA: MEDTR leads (7.60 vs 165.19). EV/Sales: MEDTR leads (1.36 vs 9.35). Dividend yield: ECILC leads (2.04% vs 0.44%). Gross margin: ECILC leads (37.83% vs 33.71%). EBITDA margin (annual): ECILC leads (11.49% vs 3.58%).
Frequently Asked Questions
Is MEDTR or ECILC cheaper?
By P/E, Tie is cheaper (66.43 vs —); by P/B, ECILC trades at the lower multiple (0.69 vs 0.68).
Which is more profitable, MEDTR or ECILC?
Annual net margin is 1.35% for MEDTR and −20.86% for ECILC; return on equity is 1.14% for MEDTR and −3.08% for ECILC.
Which is more leveraged, MEDTR or ECILC?
The leverage ratio is 15.79 for MEDTR and 18.92 for ECILC; net debt/EBITDA is — for MEDTR and 1.37 for ECILC. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.